Major News -- A landmark study, in a mainstream and peer-reviewed hyperbaric medical journal has just been released, and it supports the use of lower pressure protocols for hyperbaric medicine. This is groundbreaking, because for over two decades now, there has been a constant and heated debate going on between hyperbaric physicians on the use of low pressure protocols, and whether or not they were as effective as higher pressures. Advocates of lower pressure protocols have clearly focused their opinion on the scientific rationale of the gas pressure laws of physics and say that ANY pressure will have a physiological effect - they also have growing support from empirical data. On the other hand, skeptics of lower pressure protocols say "where is the research", and they also quote that "most of the clinical research is at higher pressures". This study should finally put these to rest. Here, they looked at 3 different pressure protocols: 1.3 ATA (ambient air), 1.5 ATA (pure oxygen), and 1.75 ATA (pure oxygen). They then added all 3 pressure protocols to a standard intensive exercise program for CP children and followed them with for an 8-month period of time. The results were astonishing. Not only did they find that all 3 hyperbaric oxygen pressures gave significant improvements, but there was no difference between the pressures. More startling to skeptics of lower pressure protocols, the lower pressure protocol did not even use the conventional pure oxygen, and instead only used regular ambient air. Why this is groundbreaking is because typically in past studies, a lower pressure protocol using regular ambient air has been used as the placebo dose in studies. This is really the point of contention. The supporters of lower pressure protocols argue "how can you use 1.3 ATA ambient air as a placebo when the laws of physics clearly show that this is actually a treatment dosage" This study clearly supports their notion pressure is the key variable in hyperbaric oxygenation therapy. Pandoras box is open! <view study> Read Less

Only 3 Sessions of Hyperbaric oxygen therapy was shown to play a positive role in the recovery of muscle injury in rats. This should hopefully lead the way to many more studies to determine its effectiveness for speeding up recovery from injured muscles and tissue <view study> Read Less

Recent research has shown that hyperbaric oxygen therapy (HBOT) can help alleviate pain both in acute and chronic cases. Much attention has focused on the anti-inflammatory effects of HBOT and associated reductions in pain. This study, published in the European Journal of Pain in 2014, showed that opioid receptors may also have a big role in the positive effects of HBOT <view study> Read Less

This animal study induced sciatic nerve injury through chronic constriction. They measured inflammatory markers and then followed up with Hyperbaric oxygenation therapy. The results demonstrated an immediate pain relief following the procedure with repetitive applications giving more long-acting relief. These results correlated with the positive changes seen in inflammatory markers and reinforce the use of hyperbaric therapy for pain and inflammation, following nerve injury <view study> Read Less

Human Embryonic stem cells have gained wide acceptance for the potential benefit of many conditions. Type 1 Diabetes is one of these conditions where this procedure is being tested. However, these stem cells have consistently failed to generate meaningful numbers of mature, functional β cells. Since oxygen is a strong driver of differentiation, researchers of this animal study looked at applying hyperbaric oxygen therapy to a group of rats following transplanted cells and observed an increase in the maturation of these cells, leading to increased insulin production. The future of embryonic stem cells may be to drive the differentiation and maturation of these cell by following the procedure with a course of hyperbaric oxygenation therapy <view study>   Read Less